News
Media coverage of HCCI’s original research

For general media inquiries or to propose collaborative projects, please contact us

May
08

From Prenatal to Postpartum Care, Total Spending on Childbirth Averaged over $25,000 among ESI Enrollees

 The high and rising costs of childbirth pose a financial challenge to many families. One study found that 60% of pregnant and postpartum women reported having difficulty affording care, with women enrolled in commercial insurance more likely to report affordability challenges than those with public insurance. To understand the average total spending on childbirth related services, as well as...

Continue reading
May
06

Facility Fees: What are they and how do they impact health care prices?

Research has shown that the price of a single service provided in a hospital outpatient department is consistently higher than the same service provided in a physician office. An earlier HCCI analysis examined 46 services that could be provided in either setting and found higher prices in outpatient departments for all services in all years studied. More recently, we evaluated prices for laborator...

Continue reading
Apr
18

Rates of Blood Cancer Diagnosis Among Private and Public Insurers

Blood cancers represent a range of diseases that can affect blood cells, bone marrow, lymph nodes, and other parts of the lymphatic system. Health care claims data can provide insights into how many people are dealing with blood cancers. Using claims data from people enrolled in Medicaid, employer-sponsored insurance (ESI), and Traditional Medicare, this data brief highlights the percentage of peo...

Continue reading
Apr
01

Off-label use of Semaglutides Continued to Grow in 2022 for those with Employer-Sponsored Insurance

Previously, HCCI analyzed Ozempic medication use in the ESI population and found that the percentage of patients using Ozempic that had a diabetes diagnosis, the condition Ozempic is clinically indicated to treat, had decreased from 92% in 2018 to 77% 2021. This indicated a growing trend of off-label use of Ozempic. Our findings aligned with reports at the time of off-label use of Ozempic for weig...

Continue reading
Mar
20

HCCI Spotlights Colorectal Cancer Awareness Month: Colorectal Cancer Screening Rates Increased 30% Among Ages 45 to 54

Colorectal cancer is the fourth most commonly diagnosed cancer in the U.S. and the second leading cause of cancer death. Recently, a growing number of young people have been diagnosed with colorectal cancer. According to the American College of Surgeons, the incidence rate of early onset colorectal cancer is expected to double by 2030. While these statistics are alarming, colon and rectal cancer a...

Continue reading